Editorial - Site-specific integration

Gene Therapy and Regulation

Volumn 2, Issue 1, 2003, Pages 1-5

  Bertolotti, Roger ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

C31 bacteriophage integrase; AAV hybrid viral vectors; AAV rep gene; Non random integration; Non viral vectors

Indexed keywords

INTEGRASE; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; BACTERIOPHAGE; BACTERIOPHAGE PHI C31; EDITORIAL; GENE EXPRESSION; GENE THERAPY; NONHUMAN; NONVIRAL GENE THERAPY; TRANSGENE; VIRAL GENE THERAPY;

ADENO-ASSOCIATED VIRUS; BACTERIOPHAGE PHI;

EID: 0037224685     PISSN: 13889532     EISSN: None     Source Type: Journal    
DOI: 10.1163/156855803762295396     Document Type: Editorial

References (31)

1. Anderson, F.W. (1998). Human gene therapy. Nature, 392 suppl.: 25-30.
2. Balague, C., Kalla, M. and Zhang, W.W. (1997). Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. J. Virol., 71: 3299-3306.
3. Berns, K.I. and Linden, R.M. (1995). The cryptic life style of adeno-associated virus. Bioessays, 17: 237-245.
4. Bertolotti, R. (2000a). Transient or long-term transgene expression and gene repair/inactivation. Gene Therapy & Regulation, 1: 1-8.
5. Bertolotti, R. (2000b). RNA and gene repair/alteration: from inherited diseases to acquired disorders and tantalizing applications for non-disease conditions. Gene Therapy & Regulation, 1: 115-122.
6. Bertolotti, R. (2001). Adult and embryonic-like stem cells: toward a major gene therapy breakthrough relying on autologous multipotent stem cells. Gene Therapy & Regulation, 1: 207-212.
7. Bushman, F. (2002). Targeting retroviral integration? Mol. Ther., 6: 570-571.
8. Cavazzana-Calvo, M., Hacein-Bey, S., de Saint Basile, G., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J.L., Bousso, P., Deist, F.L. and Fischer, A. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science, 288: 669-672.
9. Check, E. (2002). A tragic setback. Nature, 420: 116-118.
10. Groth, A.C., Olivares, E.C., Thyagarajan, B. and Calos, M.P. (2000). A phage integrase directs efficient site-specific integration in human cells. Proc. Natl. Acad. Sci. USA, 97: 5995-6000.
11. Heilbronn, R., Weller, S.K. and zur Hausen, H. (1990). Herpes simplex virus type 1 mutants for the origin-binding protein induce DNA amplification in the absence of viral replication. Virology, 179: 478-481.
12. Heister, T., Heid, I., Ackermann, M. and Fraefel, C. (2002). Herpes Simplex Virus Type 1/Adeno Associated Virus Hybrid Vectors Mediate Site-Specific Integration at the Adeno-Associated Virus Preintegration Site, AAVS1, on Human Chromosome 19. J. Virol., 76: 7163-7173.
13. Johnston, K.M., Jacoby, D., Pechan, P.A., Fraefel, C., Borghesani, P., Schuback, D., Dunn, R.J., Smith, F.I. and Breakefield, X.O. (1997). HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells. Hum. Gene Ther., 8: 359-370.
14. Kearns, W.G., Afione, S.A., Fulmer, S.B., Pang, M.C., Erikson, D., Egan, M., Landrum, M.J., Flotte, T.R. and Cutting, G.R. (1996). Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther., 3: 748-755.
15. Kotin, R.M., Siniscalco, M., Samulski, R.J., Zhu, X.D., Hunter, L., Laughlin, C.A., McLaughlin, S., Muzyczka, N., Rocchi, M. and Berns, K.I. (1990). Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA, 87: 2211-2215.
16. Linden, R.M., Ward, P., Giraud, C., Winocour, E. and Berns, K.I. (1996). Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA, 93: 11288-11294.
17. Marshall, E. (2002a). Clinical research: Gene therapy a suspect in leukemia-like disease. Science, 298: 34-35.
18. Marshall, E. (2002b). Gene therapy. What to do when clear success comes with an unclear risk? Science, 298: 510-511.
19. Olivares, E.C., Hollis, R.P., Chalberg, T.W., Meuse, L., Kay, M.A. and Calos, M.P. (2002). Site-specific genomic integration produces therapeutic Factor IX levels in mice. Nat. Biotechnol., 20: 1124-1128.
20. Ortiz-Urda, S., Thyagarajan, B., Keene, D.R., Lin, Q., Fang, M., Calos, M.P. and Khavari, P.A. (2002). Stable nonviral genetic correction of inherited human skin disease. Nat. Med., 8: 1166-1170.
21. Palombo, F., Monciotti, A., Recchia, A., Cortese, R., Ciliberto, G. and La Monica, N. (1998). Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector. J. Virol., 72: 5025-5034.
22. Philpott, N.J., Giraud-Wali, C., Dupuis, C., Gomos, J., Hamilton, H., Berns, K.I. and Falck-Pedersen, E. (2002a). Efficient integration of recombinant adeno-associated virus DNA vectors requires a p5-rep sequence in cis. J. Virol., 76: 5411-5421.
23. Philpott, N.J., Gomos, J., Berns, K.I. and Falck-Pedersen, E. (2002b). A p5 integration efficiency element mediates Rep-dependent integration into AAVS1 at chromosome 19. Proc. Natl. Acad. Sci. USA, 99: 12381-12385.
24. Pieroni, L., Fipaldini, C., Monciotti, A., Cimini, D., Sgura, A., Fattori, E., Epifano, O., Cortese, R., Palombo, F. and La Monica, N. (1998). Targeted integration of adeno-associated virus-derived plasmids in transfected human cells. Virology, 249: 249-259.
25. Recchia, A., Parks, R.J., Lamartina, S., Toniatti, C., Pieroni, L., Palombo, F., Ciliberto, G., Graham, F.L., Cortese, R., La Monica, N. and Colloca, S. (1999). Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector. Proc. Natl. Acad. Sci. USA, 96: 2615-2620.
26. Sclimenti, C.R., Thyagarajan, B. and Calos, M.P. (2002). Directed evolution of a recombinase for improved genomic integration at a native human sequence. Nucleic Acids Res., 29: 5044-5051.
27. Surosky, R.T., Urabe, M., Godwin, S.G., McQuiston, S.A., Kurtzman, G.J., Ozawa, K. and Natsoulis, G. (1997). Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J. Virol., 71: 7951-7959.
28. Thyagarajan, B., Olivares, E.C., Hollis, R.P., Ginsburg, D.S. and Calos, M.P. (2002). Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol. Cell Biol., 21: 3926-3934.
29. Wang, Y., Camp, S.M., Niwano, M., Shen, X., Bakowska, J.C., Breakefield, X.O. and Allen, P.D. (2002). Herpes simplex virus type 1/adeno-associated virus rep(+) hybrid amplicon vector improves the stability of transgene expression in human cells by site-specific integration. J. Virol., 76: 7150-7162.
30. Weitzman, M.D., Fisher, K.J. and Wilson, J.M. (1996). Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers. J. Virol., 70: 1845-1854.
31. Young, S.M. and Samulski, R.J. (2001). Adeno-associated virus (AAV) site-specific recombination does not require a Rep-dependent origin of replication within the AAV terminal repeat. Proc. Natl. Acad. Sci. USA, 98: 13525-13530.